Protara Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Protara Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2013 to Q2 2024.
  • Protara Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 21.2M shares, a 87.8% increase year-over-year.
  • Protara Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 11.3M shares, a 0.64% increase from 2022.
  • Protara Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 11.3M shares, a 0.24% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 21.2M +9.93M +87.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 11.4M +117K +1.04% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 11.3M +71.7K +0.64% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 11.3M +82.4K +0.73% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 11.3M +52.6K +0.47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 11.3M +53.7K +0.48% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 11.3M +27K +0.24% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 11.3M +30K +0.27% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 11.3M +23.2K +0.21% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 11.3M +23.2K +0.21% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 11.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 11.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 11.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 11.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2014 12.3M +12.1M +5025% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 241K +1.14K +0.48% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 240K +9.77K +4.24% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 240K +9.53K +4.13% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 240K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-20
Q3 2013 239K Jul 1, 2013 Sep 30, 2013 10-K 2015-03-20
Q2 2013 231K Apr 1, 2013 Jun 30, 2013 10-K 2015-03-20
Q1 2013 231K Jan 1, 2013 Mar 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.